Precision Medicine: Identifying Targeted Cancer Treatments with Genomic Testing
Precision, or personalized, medicine has made a sea-change in cancer treatment. A pipe dream for most patients 10 years ago, it is a reality today. Precision Medicine's keystone is the ability to identify personal gene characteristics and match them to specific treatment options. This discussion will consider many questions surrounding precision medicine and targeted treatment, helping to answer:
- Genetic (germline) versus genomic (somatic) testing
- Who should get tested and for what?
- Getting tested and educating your doctor
- The pros and cons of testing
- Is gene testing affordable?
- What is an actionable mutation?
- How do actionable mutations impact treatment?
- Immunotherapy and personalized medicine
We have a knowledgeable panel of physicians, patients and patient advocates to help patients, caregivers and advocates understand precision medicine and targeted treatment, including David Marshak, Manager Patient Advocacy at Foundation Medicine, based in Cambridge, Massachusetts. Foundation Medicine performs comprehensive genomic sequencing to identify the molecular alterations in each patient's unique cancer and match them with relevant targeted therapies, immunotherapies, and clinical trials.
Rick Davis will be moderating the panel. Rick is a nationally recognized patient advocate and Founder of Answer Cancer Foundation. Diagnosed with locally advanced prostate cancer in 2007 and treated with radiation and hormone therapy, Rick moderates AnCan's High Risk/Recurrent/Advanced Prostate Cancer virtual support group, a weekly online & telephone group.